Long-Term Follow-up of Onychomycosis Patients Treated With Efinaconazole.

CONCLUSIONS: This single-center phase 4 study supports previous data showing good efficacy and tolerability of efinaconazole in moderately severe onychomycosis. Continued reduction in disease severity post-treatment suggest that a longer follow-up of patients treated with efinaconazole would afford better efficacy results, as indicated by greater treatment success, and increase in number of subjects who became complete cures.</p> <p><em>J Drugs Dermatol. 2017;16(12):1269-1273.</em></p>. PMID: 29240863 [PubMed - in process]
Source: Journal of Drugs in Dermatology - Category: Dermatology Tags: J Drugs Dermatol Source Type: research